Neoadjuvant and adjuvant therapy for renal cell carcinoma: critique, current trials and future directions
The following articles discuss the use of neoadjuvant therapy (drug [...]
Adjuvant therapy in renal cell carcinoma: a review of the clinical trials to date
The number of drugs available to fight advanced renal cell carcinoma [...]
Adjuvant pazopanib shows no benefit for locally-advanced kidney cancer
Results from the phase 3 PROTECT clinical trial, which compared [...]
Type of long-term response to targeted therapy affects outcomes for advanced kidney cancer
A retrospective study conducted by researchers in the Czech Republic [...]
Neoadjuvant and adjuvant therapy for kidney cancer
A comprehensive review of neoadjuvant therapy and adjuvant therapy for [...]
Advances in kidney cancer drug treatments shake up drug choices
The following article provides a comprehensive summary of the changing [...]
First patient dosed in pivotal phase 3 clinical trial of tivozanib in renal cell carcinoma
AVEO Oncology has enrolled and dosed the first patient in [...]
Adjuvant sunitinib or sorafenib don’t prevent recurrence of kidney cancer
Results from the ASSURE clinical trial have recently been published [...]
Adjuvant sunitinib or sorafenib for high risk kidney cancer
A study published in The Lancet last week reported that [...]
